|
ZFP106 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.74990000162612E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.248500E-04 |
| Normal-vs-Stage2 |
2.481400E-03 |
| Normal-vs-Stage3 |
1.364540E-04 |
| Normal-vs-Stage4 |
5.82970000051475E-08 |
| Stage1-vs-Stage2 |
8.854000E-01 |
| Stage1-vs-Stage3 |
9.095600E-01 |
| Stage1-vs-Stage4 |
1.945030E-01 |
| Stage2-vs-Stage3 |
7.879600E-01 |
| Stage2-vs-Stage4 |
2.035000E-01 |
| Stage3-vs-Stage4 |
2.763400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.93853830157786E-12 |
| Normal-vs-AfricanAmerican |
3.223600E-01 |
| Normal-vs-Asian |
1.04540000001041E-06 |
| Caucasian-vs-AfricanAmerican |
3.701800E-01 |
| Caucasian-vs-Asian |
4.908800E-01 |
| AfricanAmerican-vs-Asian |
1.570400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64401825486493E-12 |
| Normal-vs-Female |
6.192800E-01 |
| Male-vs-Female |
3.982500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.851600E-01 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.89260000396752E-08 |
| Normal-vs-Extreme_Obese |
2.00740000000366E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.563750E-01 |
| Normal_Weight-vs-Obese |
3.771400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.064400E-01 |
| Extreme_Weight-vs-Obese |
6.995600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.446200E-01 |
| Obese-vs-Extreme_Obese |
7.133800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.286800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.441850E-02 |
| Normal-vs-Age(61-80Yrs) |
6.52811138479592E-14 |
| Normal-vs-Age(81-100Yrs) |
5.484000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.673000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.181600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.058000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.778590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.608600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.313600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
5.689400E-01 |
| Normal-VS-KIRP CIMP |
6.75849999964839E-07 |
| Normal-VS-Unclassified PRCC |
2.761800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.109600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.269800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.735600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.008380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.123400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.514200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.919400E-03 |
| Normal-vs-N1 |
2.26210050691122E-10 |
| Normal-vs-N2 |
9.8668000000024E-05 |
| N0-vs-N1 |
2.480400E-01 |
| N0-vs-N2 |
6.386400E-01 |
| N1-vs-N2 |
7.374000E-01 |
|
|
